Evidence map›Paper›PMID 41027897›Full record

ArticleNature communications2025

Design and evolution of artificial enzyme with in-situ biosynthesized non-canonical amino acid.

Wei Huang, Shiping Wang, Ya Wei, Yuting Bai, Zhixi Zhu, Dejing Yin, Tao Liu, Xiang Sheng, Zhi Zhou

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Reprogramming NAD(P)Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei Huang *School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China.ORCID http://orcid.org/0000-0002-7412-3965
Shiping Wang *State Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Ya WeiSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China.
Yuting BaiSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China.
Zhixi ZhuSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China.
Dejing YinSchool of Biotechnology, Jiangnan University, Wuxi, China.
Tao LiuState Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-5347-5892
Xiang ShengState Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China. shengx@tib.cas.cn.ORCID http://orcid.org/0000-0002-6542-6649
Zhi ZhouSchool of Life Sciences and Health Engineering, Jiangnan University, Wuxi, China. zhouzhi@jiangnan.edu.cn.ORCID http://orcid.org/0000-0001-7926-118X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22207043Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation) BK20221092
6 · The paper itself

Abstract

The creation of designer enzymes by incorporating genetically encoded non-canonical amino acids (ncAAs) could significantly expand the catalytic repertoire of the enzyme universe for abiological transformations. However, due to the limited availability of ncAAs with potential catalytic functional groups, progress in this field remains relatively slow. Herein, we present an efficient approach for enzyme design with organocatalytic ncAAs by integrating the biosynthesis and genetic incorporation of ncAAs harboring abiological catalytic residues into the protein scaffold. Based on this ncAAs in situ biosynthesis and incorporation system, our designer enzyme with an unnatural mercapto-aniline residue is created efficiently by feeding thiols to E. coli and shows significant catalytic activity for an enantioselective Friedel-Crafts alkylation reaction with excellent enantioselectivity and reactivity after directed evolution. This study provides a universal strategy for designing artificial enzymes with xenobiotic catalytic moieties with diverse biosynthesized ncAAs, thereby expanding the toolbox of biocatalysts for abiological transformations.

Indexed as

Amino AcidsDirected Molecular EvolutionEnzymesProtein EngineeringAlkylationBiocatalysisEscherichia coliStereoisomerismSulfhydryl CompoundsAmino AcidsEnzymesSulfhydryl Compounds

Identifiers

PMID41027897
PMCPMC12485135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.